SYMPATHOMIMETIC DRUGS

Slides:



Advertisements
Similar presentations
Catecholamine Agonists and Antagonists. Need-to-know Drugs Norepinephrine Norepinephrine Alpha 1 & 2 and Beta 1 agonist Alpha 1 & 2 and Beta 1 agonist.
Advertisements

Sympathetic Drugs. Stress and The Adrenal Glands.
PHARMACOLOGY OF SNS.
Drugs Affecting Peripheral Nervous System #2. Fight or Flight versus the Parasympathetic Pig.
Pharmacology-1 PHL 211 Fourteenth Lecture By Abdelkader Ashour, Ph.D. Phone:
Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology
Adrenergic agonists Samuel Aguazim (MD).
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
SYMPATHOMIMETIC DRUGS
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 17 Adrenergic Agonists.
Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics According to spectrum of action According to chemistry According to mode.
Chapter 5 Autonomic Drugs.
ADRENERGIC ANTAGONITS
PHARMAKOLOGY VASOPRESSOR DRUGS DJUDJUK RAHMAD BASUKI Lab.Anestesi dan Terapi Intensive RSSA Malang.
Autonomic Nervous System
Adrenergic Agonists Dr. Asmah Nasser, M.D..
Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab.DCA, Dip. Software statistics- Ph d Mahatma Gandhi Medical college and research institute, puducherry,
ADRENERGIC RECEPTORS AND DRUGS
Adrenergic antagonist sympatholytic
Adrenergic Agonists (Sympathomimetics)
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Adrenergic Drugs  Adrenergic receptors are divided into two major types according to drug potency on the receptors  Alpha-(α-) adrenergic receptors,
Sympathomimetics (continue)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 19 Indirect-Acting Antiadrenergic Agents.
Adrenergic agonists Samuel Aguazim (MD).
Bronchodilators Lilley Pharmacology Text: Chapter 35
Adrenoceptor Agonists & Sympathomimetic Drugs
Synthesis & Release of Neurotransmitters
1 Adrenergic Receptor Agonists Termed sympathomimetic drugs Divided into three groups Direct-acting agonists –Catecholamines –Noncatecholamines Indirect-acting.
Chapter 19 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
Adrenergic Agonists Prof. A. Alhaider. Tyrosine Dopa DA NE Na COMT NET Ca Norepinephrine (NE) SYNTHESIS STORAGE RELEASE ACTION REUPTAKE DEGRADE POSTGANGLIONIC.
AUTONOMICS MA. JANETTH B. SERRANO, M.D. DPBA. Site and Mode of Action: Site and Mode of Action: 1. Direct Acting –Epinephrine- Dobutamine –Phenylephrine-
HuBio 543 September 26, 2007 Neil M. Nathanson K-536A, HSB Adrenergic Agonists &Other Sympathomimetics.
Adrenergic & Antiadrenergic Drugs By Prof. Alhaider.
Adrenoceptor activating & Other Sympathomimetic drugs Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
Sympathomimetic Agents
Part 4 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
Lecture 11b Clinical uses of adrenergic agonists.
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
Lecture 7 Summary –Adrenalin (α & β): ↑ systolic BP & slight ↓diastolic BP –NA: (α & β1) ↑ systolic & diastolic BP + Reflex bradycardia –Isoproterenol.
Sympathomimetics Review 28 February :25 PM.
Sympathetic Nervous System.
Adrenergic agonists Saja Hamed, Ph.D.
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF ANS part 2 General Pharmacology M212.
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
Drug action on Sympathetic Nerves: No. 3: Sympatholytic drugs
SYMPATHOMIMETIC AGENTS
Adrenergic Drugs.
Adrenergic Agonists.
Sympatholytic & adrenergic blockers -receptor Antagonists
Department of Pharmacology
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
على قدر الهدف يكون الانطلاق.
ADRENERGIC MEDICATIONS (sympathomimetic drugs)
Adrenoceptor Agonists & Sympathomimetic Drugs
Adrenergic agonist: PHARMACOLOGY OF SNS.
SYMPATHETIC NERVOUS SYSTEM
Sympatholytic & adrenergic blockers -receptor Antagonists
Pharmacological actions of cathecholamines
Sympathomimetics Domina Petric, MD.
Adrenergic agonists.
Characteristics of Adrenergic Drugs (p. 291)
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Content Introduction. Types of adrenergic drugs. Types of adrenergic receptor. Classification. Application of adrenergic drugs. References.
Adrenergic agonists and antagonists
Adrenergic System And Drugs  Adrenergic transmission  Adrenergic receptor  Adrenergic drugs  Therapeutic classification of adrenergic drugs  Pharmacological.
SNS Drugs Anita Bolina 23rd March 2019.
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic agonists ILOS
Adrenergic Agonists.
Presentation transcript:

SYMPATHOMIMETIC DRUGS

ALPHA ADRENERGIC AGONISTS 1-Selective Agonists Major effects due to stimulation of 1 receptors in vascular smooth muscle Increase in peripheral vascular resistance & BP Clinical utility limited – some use in hypotension and shock states

1 – Selective Agonists Phenylephrine Direct simulation of 1 receptors Methoxamine Methoxamine: Relatively selective 1-agonist; No action at  receptors. CV effects :  BP, Reflex bradycardia May be used IV in hypotensive states Phenylephrine: 1 selective,  actions at much higher doses Effects similar to methoxamine Uses: nasal decongestant, mydriatic – local instillation

1 – Selective Agonists Xylometazoline Oxymetazoline Naphazoline: Direct 1 – agonists, Used as nasal decongestants Rebound hyperaemia occurs

Used primarily for treatment of systemic hypertension. Selective actions on 2-adrenoceptors Decrease release of NE from presynaptic terminals Act at brainstem level to  central sympathetic tone 2 – Selective Agonists

2 – Selective Agonists Clonidine:– Selective action on 2 (partial agonist with high affinity) Developed as a nasal decongestant Produces hypotension, sedation, bradycardia and mild analgesia Major effects on BP IV :  in BP (peripheral  receptors on blood vessels) – short lasting Followed by prolonged hypotensive effect Mainly central (lower brainstem) +  NE release from terminals. Oral: The early hypertensive phase is not seen Additional effects: Bradycardia ( Vagal tone) Sedation Mild analgesia

Clonidine…. Well absorbed orally – 100 % bioavailability Peak effect 1-3 hours 50 % excreted unchanged ADVERSE EFFECTS : Dry mouth, sedation, sexual dysfunction Marked bradycardia in some Rebound hypertension following sudden stoppage USES: Hypertension Tt. of symptoms of narcotic withdrawal Menopausal hot flashes (lower doses) Guanfacine and Guanabenz : similar to clonidine

2 – Selective Agonists α-Methyldopa : Converted to α-MNA which acts like clonidine Prodrug Tizanidine: Has same effects like clonidine Used mainly for relieving muscle spasticity of cerebral or spinal origin Apraclonidine: Used locally to  IO pressure ? aqueous formation

BETA ADRENERGIC AGONISTS Isoproterenol ( Isoprenaline) Synthetic catecholamine Extremely potent  receptor agonist – NON SELECTIVE Little effect on  receptors +ve inotropic and chronotropic actions – palpitations, HR, arrhythmias Potent vasodilator – marked  in CO,  in diastolic and mean BP Relaxes all smooth muscles (esp. bronchial and GIT) USES: Bradycardia and heart block – has been replaced by other drugs

(also has  receptor actions) DOBUTAMINE : 1- selective agonist (also has  receptor actions) Resembles Dopamine But no action on DA receptors Major actions are  receptor mediated EFFECTS: +ve inotropic and chronotropic effects > isoprenaline  in SA node automaticity < than Isoprenaline Total peripheral resistance not affected much

DOBUTAMINE : ADVERSE EFFECTS: Excessive  in HR and BP (specially in hypertensives) Ventricular ectopics may occur  in infarct size in MI – ( in oxygen demand) Tolerance to effects may develop in some cases USES: Short term Tt. of cardiac decompensation eg. Cardiac surgery, MI Plasma t ½ of 2 minutes hence given by infusion

2- selective agonists Selectivity is relative – lost at higher doses Developed mainly for use as Bronchodilators with low CV effects Also used for Uterine Relaxant effect

2- selective agonists Terbutaline, Albuterol (salbutamol), Metaproterenol , Salmeterol Not metabolized by COMT -- Better oral bioavailability Pharmacological effects: Bronchodilatation - 2 receptors on bronchial smooth muscle May also :- Suppress release of leukotrienes and histamine Enhance mucociliary function  microvascular permeability  phospholipase A2 activity Uterine relaxant action -- 2 receptors on uterine muscle

2- selective agonists Adverse effects: Mainly due to excessive dosage loss of selectivity 1 CVS effects Adverse effects are limited when used by inhalational route in Asthma Terbutaline and Albuterol : Effective orally, sc, inhalation Rapid onset, duration 3 – 6 hrs Use: Long term Tt of COPD ; Ac bronchospasm; Tocolytic Metaproterenol : less 2 selective

2- selective agonists Salmeterol : 2 selective and long acting (12 hours) Onset of action slow Not suitable alone for Acute attack Ritodrine: Developed specially as a uterine relaxant Properties similar to other agents Rapidly absorbed after oral intake Administered IV to arrest premature labour

Receptor Affinity Alpha agonists Phenylephrine, methoxamine Clonidine, MNA α1> α2 >>>>> β α2> α1 >>>>> β Mixed α and β agonists Noradrenaline Adrenaline α1= α2 ; β1>> β2 α2= α1 ; β1= β2 Beta agonists Dobutamine Isoproterenol Terbutaline, Albuterol, Ritrodine β1> β2 >>>> α β1= β2 >>>> α β2 > β1 >>>> α Dopamine agonists Dopamine D1 = D2 >> β >> α

INDIRECTLY ACTING SYMPATHOMIMETICS By releasing catecholamines from neurones Amphetamine: Powerful CNS stimulant actions Orally effective Abused for psychic effects wakefulness, mood elevation, alertness,  self-confidence, concentration,  fatigue Performance enhanced but chances of errors ↑ Tolerance occurs Long term use followed by fatigue and exhaustion Toxicity: Acute – extension of sympathomimetic effects Chronic – Wt. Loss, psychotic reactions, dependence Uses: Narcolepsy Attention-deficit hyperactivity disorder Obesity - apetite suppression ?

INDIRECTLY ACTING SYMPATHOMIMETICS Tyramine : Not used clinically Importance – Present in several foods (cheese, beer, red wine) Interaction with MAO inhibitors : severe toxic effects – severe hypertensive crisis “Cheese Reaction” Methylphenidate : Structurally related to amphetamine Mild CNS stimulant – actions on mental > motor functions Used for Attention-deficit hyperactivity disorder Modafinil : Newer agent, Similar to amphetamine , lower side effects

INDIRECTLY ACTING SYMPATHOMIMETICS Ephedrine : (& pseudoephedrine) Mixed actions ( release + direct effects ) Stimulates  and  receptors Effective orally:  BP, HR, Bronchodilatation, CNS ↑ Duration : several hours – t1/2 3-6 hrs ; Tachyphylaxis occurs USES: Bronchodilator, decongestant ADVERSE EFFECTS :  BP, Insomnia, Urinary retention in elderly

INDIRECTLY ACTING SYMPATHOMIMETICS Mephentermine Direct & + Metaraminol Indirect (release of NE) Effects due to 1 stimulation + Indirect ( + ) HR, force of contraction, CO, systolic and diastolic BP. Uses : To prevent excessive hypotension during spinal anaesthesia, Other hypotensive states To relieve attacks of PAT Adverse effects: CNS stimulation, Excessive  BP, Arrhythmias

THERAPEUTIC USES OF SYMPATHOMIMETIC AGENTS Shock Hypotensive states Hypertension (2 –agonists) Local vascular effects Nasal decongestant (α1 agonists) Ophthalmic uses {Mydriasis (α1); Glaucoma (α2) Asthma and COPD (β2 agonists) Allergic reactions Narcolepsy Weight reduction Attention-deficit hyperactivity disorder in children Tocolytic (2 – agonists)

INDIRECTLY ACTING SYMPATHOMIMETICS B. By blocking reuptake of released transmitter Cocaine : Peripheral sympathomimetic actions, Amphetamine like CNS actions - drug of abuse.

Alpha methyl DOPA Alpha methyl DA Alpha methyl NA ( selective action on α2 )